ASTRAZENECA PLC (AZN)
Clinical trial NCT05417594 updates: 1. completion date: 2027-11-01 → 2028-02-07 2. primary completion date: 2027-11-01 → 2028-02-07
Clinical trial NCT05417594 updates: 1. completion date: 2027-11-01 → 2028-02-07 2. primary completion date: 2027-11-01 → 2028-02-07
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical